Cristiano Gonçalves Pereira

Cristiano Gonçalves Pereira

Instituto Butantan - São Paulo / Brazil
Business & Management / Entrepreneurship
AD Scientific Index ID: 903838
Butantan Institute
person_outline Cristiano Gonçalves Pereira's MOST POPULAR ARTICLES
1-) Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma YNV Gopal, H Rizos, G Chen, W Deng, DT Frederick, ZA Cooper, ... Cancer research 74 (23), 7037-7047, 2014 1712014
2-) Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target G Chen, N Chakravarti, K Aardalen, AJ Lazar, MT Tetzlaff, B Wubbenhorst, ... Clinical Cancer Research 20 (21), 5537-5546, 2014 1642014
3-) Emerging patent landscape for non-viral vectors used for gene therapy V Picanço-Castro, CG Pereira, DT Covas, GS Porto, A Athanassiadou, ... Nature biotechnology 38 (2), 151-157, 2020 422020
4-) Forecasting of emerging therapeutic monoclonal antibodies patents based on a decision modelCG Pereira, JR Lavoie, E Garces, F Basso, M Dabić, GS Porto, T DaimTechnological Forecasting and Social Change 139, 185-199, 2019412019
5-) Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiationBCMF Paes, PD Moço, CG Pereira, GS Porto, EM de Sousa Russo, ...Cell biology and toxicology 33, 233-250, 2017392017